Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$418M |
| 2 |
AGN
Allergan plc
AGN
|
+$403M |
| 3 |
GGP
GGP Inc.
GGP
|
+$268M |
| 4 |
Starbucks
SBUX
|
+$204M |
| 5 |
American Airlines Group
AAL
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$769M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$597M |
| 3 |
Apple
AAPL
|
+$280M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$165M |
| 5 |
Johnson & Johnson
JNJ
|
+$129M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14% |
| 2 | Financials | 13.9% |
| 3 | Technology | 13.71% |
| 4 | Industrials | 10.96% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Village Super Market
VLGEA
$631M
| $2.54M | ﹤0.01% |
80,939
+81
| +0.1% | +$2.33K |
|
|
VIVS
2952
VivoSim Labs
VIVS
$1.17M
| $2.54M | ﹤0.01% |
2,992
+5
| +0.2% | +$6.91K |
|
|
PAMT
2953
PAMT Corp
PAMT
$275M
| $2.53M | ﹤0.01% |
177,008
-33,808
| -16% | -$467K |
|
2954
Gerdau
GGB
$9.42B
| $2.53M | ﹤0.01% |
996,993
-275,563
| -22% | -$765K |
|
|
RPRX
2955
DELISTED
Repros Therapeutics Inc.
RPRX
| $2.53M | ﹤0.01% |
294,751
+760
| +0.3% | +$6.8K |
|
2956
Winmark
WINA
$1.26B
| $2.53M | ﹤0.01% |
28,898
-1,924
| -6% | -$158K |
|
|
ACI
2957
DELISTED
ARCH COAL, INC.
ACI
| $2.53M | ﹤0.01% |
253,081
+15,255
| +6% | +$177K |
|
2958
NWPX Infrastructure Inc
NWPX
$1.1B
| $2.53M | ﹤0.01% |
110,222
-877
| -0.8% | -$21.4K |
|
|
VVUS
2959
DELISTED
Vivus Inc
VVUS
| $2.53M | ﹤0.01% |
102,783
+1,617
| +2% | +$44.9K |
|
2960
Reading International Class A
RDI
$32.9M
| $2.53M | ﹤0.01% |
187,800
+2,557
| +1% | +$32.5K |
|
|
FBNK
2961
DELISTED
First Connecticut Bancorp, Inc
FBNK
| $2.52M | ﹤0.01% |
164,042
-2,355
| -1% | -$35.8K |
|
|
ANR
2962
DELISTED
Alpha Natural Resources Inc
ANR
| $2.51M | ﹤0.01% |
2,513,696
+168,535
| +7% | +$192K |
|
|
TREC
2963
DELISTED
Trecora Resources
TREC
| $2.51M | ﹤0.01% |
205,773
-2,020
| -1% | -$27.7K |
|
|
GOLD
2964
DELISTED
Randgold Resources Ltd
GOLD
| $2.51M | ﹤0.01% |
36,438
+336
| +0.9% | +$25.3K |
|
|
CDMO
2965
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.49M | ﹤0.01% |
263,685
+2,438
| +0.9% | +$23.5K |
|
2966
Civeo
CVEO
$342M
| $2.49M | ﹤0.01% |
81,682
-1,000
| -1% | -$39.1K |
|
|
SEP
2967
DELISTED
Spectra Engy Parters Lp
SEP
| $2.48M | ﹤0.01% |
47,975
-56,591
| -54% | -$3.03M |
|
|
BEAT
2968
DELISTED
BioTelemetry, Inc.
BEAT
| $2.48M | ﹤0.01% |
280,623
-4,106
| -1% | -$41.5K |
|
2969
Tilly's
TLYS
$122M
| $2.48M | ﹤0.01% |
158,551
-29,142
| -16% | -$389K |
|
|
NAVB
2970
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
| $2.48M | ﹤0.01% |
77,979
+3,148
| +4% | +$107K |
|
|
DEST
2971
DELISTED
Destination Maternity Corporation
DEST
| $2.48M | ﹤0.01% |
164,340
+577
| +0.4% | +$9.06K |
|
|
GIFI
2972
DELISTED
Gulf Island Fabrication
GIFI
| $2.47M | ﹤0.01% |
166,072
-5,218
| -3% | -$84.7K |
|
|
ECYT
2973
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $2.46M | ﹤0.01% |
393,156
-1,538
| -0.4% | -$8.88K |
|
|
JUNO
2974
DELISTED
Juno Therapeutics, Inc.
JUNO
| $2.46M | ﹤0.01% |
+40,539
| New | +$1.97M |
|
2975
Ocular Therapeutix
OCUL
$2.28B
| $2.46M | ﹤0.01% |
58,470
+86
| +0.1% | +$2.83K |
|
Similar funds
Northern Trust's Q1 2015 Portfolio in Review
As of Q1 2015, Northern Trust held 4,454 positions worth $333B, up 0.39% from $331B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Northern Trust's Q1 2015 filing shows 185 new, 2,333 increased, 1,613 reduced and 120 closed positions. Its largest new stake was Qorvo: 2,554,147 shares worth $204M. The largest sale was Allergan Inc, an estimated $769M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Financials and Technology.
- Northern Trust's largest Q1 2015 buy was Qorvo: 2,554,147 shares worth $204M.
- Northern Trust added most to Medtronic in Q1 2015, an estimated $418M increase.
- Northern Trust's biggest Q1 2015 reduction was Apple, cutting an estimated $280M.
- Northern Trust fully exited Allergan Inc in Q1 2015, selling an estimated $769M.
- Northern Trust's ten largest holdings make up 13% of its $333B portfolio in Q1 2015.
- Northern Trust opened 185 new positions and closed 120 in Q1 2015.
- Northern Trust's portfolio value rose 0.39% quarter-over-quarter to $333B.
Based on Northern Trust's 13F filing for Q1 2015, filed 14 May 2015.